Navigation Links
Reportlinker Adds 2010 U.S. Ophthalmologists' Assessment of Eye Care Medication Brands
Date:7/8/2010

NEW YORK, July 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0236247/2010-US-Ophthalmologists-Assessment-of-Eye-Care-Medication-Brands.html

This study encompasses feedback provided by U.S. physicians on aspects of ophthalmology drug treatment, enabling interested stakeholders to gain insight into current and future trends. Frost & Sullivan conducted a web-based survey of 152 U.S. Ophthalmologists in November 2009. Of these respondents, 48 percent are in single-specialty group practice, 38 percent are in solo practice, and the rest are in multi-specialty group practice or in hospital-based clinics. 

Please note that Table of Contents numbering has been standardized and may not match numbering within the publication.

1: Research Objectives, Method Details, and Segmentation

1.1: Research Objectives and Method Details

Table 1: Research Objectives and Method Details

1.2: Segmentation

2: Executive Summary

2.1: Patient Compliance to Eye Care Medications

2.2: Factors Impacting Eye Care Medication Prescriptions

2.3: Ophthalmologists' Preferences and Brand Loyalty When Prescribing Eye Care Medications

Table 2: Ophthalmologists' Preferences and Brand Loyalty When Prescribing Eye Care Medications

3: Patient Compliance with Eye Care Medications

3.1: Assessment of Patient Compliance

3.2: Analyst Comments

3.3: Average Number of Medications Taken by Glaucoma Patients

4: Factors Impacting Prescriptions of Eye Care Medications

4.1: Eye Care Medications: Most Important Features

4.2: Other Factors Correlateda/ with Efficacy, the Most Important Factor for Prescribing Eye Care Medications

4.3: Patients' Involvement in Eye Care Medication Selection Process

5: Preferences for Glaucoma Medications

5.1: Prostaglandin Analogues for Glaucoma

5.1.1: Primary Brand Use and Brand Reputation

5.1.2: Brand Loyalty

5.2: Beta Blockers for Glaucoma

5.2.1: Primary Brand Use and Brand Reputation

5.2.2: Brand Loyalty

5.3: Combination Therapies for Glaucoma

5.3.1: Primary Brand Use and Brand Reputation

5.3.2: Brand Loyalty

5.4: Carbonic Anhydrase Inhibitors for Glaucoma

5.4.1: Primary Brand Use and Brand Reputation

5.4.2: Brand Loyalty

5.5: Alpha Adrenergic Agonists for Glaucoma

5.5.1: Primary Brand Use and Brand Reputation

6: Preferences for Other Eye Disease Medications

6.1: Age-Related Macular Degeneration Medications

6.1.1: Primary Brand Use and Brand Reputation

6.1.2: Brand Loyalty

6.1.3: Lucentis Versus Avastin

6.2: Allergic Conjunctivitis Medications

6.2.1: Primary Brand Use and Brand Reputation

6.2.2: Brand Loyalty

6.3: NSAID Medications

6.3.1: Primary Brand Use and Brand Reputation

6.3.2: Brand Loyalty

7: Appendices

7.1: Preferences for Glaucoma Medications

7.1.1: Prostaglandin Analogues for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.2: Beta Blockers for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.3: Combination Therapies for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.4: Carbonic Anhydrase Inhibitors for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.2: Preferences for Other Eye Disease Medications

7.2.1: Age-Related Macular Degeneration Medications: Reasons for Top Ranking - Sample of Verbatim Comments

7.2.2: Allergic Conjunctivitis Medications: Reasons for Top Ranking - Sample of Verbatim Comments

7.2.3: NSAID Medications: Reasons for Top Ranking - Sample of Verbatim Comments

To order this report:

Drug and Medication Industry:

Drug and Medication Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
(Date:9/9/2017)... , Sept. 8, 2017 Dealmed Medical Supplies, ... supplier of medical equipment, supplies, drugs, vaccines, and specialty ... entered into an agreement to acquire Vantage Medical Supplies, ... in Holtsville, New York . ... supplying new and emerging medical practices, will operate under ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... Presenting ... Benefit Administrators (SPBA) hosted “Expanding Your Success” with an educational emphasis. , ... focused on best practices for third party administrators (TPAs) related to health plan ...
(Date:9/19/2017)... ... September 19, 2017 , ... The Semper Fi Fund, one of ... release of a series of videos and a compelling documentary that provide unique insights ... United States as part of its ongoing mission. , Each of the videos focuses ...
(Date:9/19/2017)... ... September 19, 2017 , ... Public outrage over the toxins ... fallen on deaf ears, leaving the water industry itself to research, develop and ultimately ... of the curve in the field of natural alkaline water technologies, ...
(Date:9/19/2017)... (PRWEB) , ... September 19, ... ... memory-enhancing and cognitive health supplement developed by a neurosurgeon, has received a ... retailers. , Daily Brain Booster is currently available on the Wal-Mart ...
(Date:9/19/2017)... TX (PRWEB) , ... September 19, 2017 , ... ... the United States, named Dr. Howard Ng, as the new Medical Director of its ... be the new facility Medical Director of our Pflugerville- FM 685 location,” said Dr. ...
Breaking Medicine News(10 mins):